Global changes in food supply and the obesity epidemic
Abstract Purpose of Review We explore how a global shift in the food system caused by
global economic growth, increase in available food per capita and in food processing is a …
global economic growth, increase in available food per capita and in food processing is a …
Targeting epicardial adipose tissue with exercise, diet, bariatric surgery or pharmaceutical interventions: a systematic review and meta‐analysis
N Launbo, EH Zobel, BJ von Scholten… - Obesity …, 2021 - Wiley Online Library
Epicardial adipose tissue (EAT) and pericardial adipose tissue (PAT) are metabolically
active fat depots implicated in cardiovascular disease, and EAT has potential as a novel …
active fat depots implicated in cardiovascular disease, and EAT has potential as a novel …
Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective …
N Tofte, M Lindhardt, K Adamova… - The lancet Diabetes & …, 2020 - thelancet.com
Background Microalbuminuria is an early sign of kidney disease in people with diabetes and
indicates increased risk of cardiovascular disease. We tested whether a urinary proteomic …
indicates increased risk of cardiovascular disease. We tested whether a urinary proteomic …
Optimization of albuminuria-lowering treatment in diabetes by crossover rotation to four different drug classes: a randomized crossover trial
VR Curovic, N Jongs, MYAM Kroonen, EH Zobel… - Diabetes …, 2023 - Am Diabetes Assoc
OBJECTIVE Renin–angiotensin system (RAS) inhibitors decrease the urinary albumin to
creatinine ratio (UACR) but are ineffective in up to 40% of patients. We hypothesized that …
creatinine ratio (UACR) but are ineffective in up to 40% of patients. We hypothesized that …
[HTML][HTML] Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with …
EH Zobel, BJ von Scholten, H Reinhard… - Cardiovascular …, 2017 - Springer
Background To evaluate symmetric dimethylarginine (SDMA) and asymmetric
dimethylarginine (ADMA) as risk markers of cardiovascular disease, all-cause mortality and …
dimethylarginine (ADMA) as risk markers of cardiovascular disease, all-cause mortality and …
[HTML][HTML] Effect of liraglutide on expression of inflammatory genes in type 2 diabetes
EH Zobel, RS Ripa, BJ von Scholten… - Scientific reports, 2021 - nature.com
Anti-inflammatory effects of glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment
in T2D may contribute to the cardiovascular benefits observed with GLP-1 RAs in outcome …
in T2D may contribute to the cardiovascular benefits observed with GLP-1 RAs in outcome …
[HTML][HTML] Effect of 26 weeks of liraglutide treatment on coronary artery inflammation in type 2 diabetes quantified by [64Cu] Cu-DOTATATE PET/CT: results from the …
JK Jensen, EH Zobel, BJ von Scholten… - Frontiers in …, 2021 - frontiersin.org
Background Quantification of coronary artery inflammation and atherosclerosis remains a
challenge in high-risk individuals. In this study we sought to investigate if the glucagon like …
challenge in high-risk individuals. In this study we sought to investigate if the glucagon like …
Effect of Liraglutide on Arterial Inflammation Assessed as [18F]FDG Uptake in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial
RS Ripa, EH Zobel, BJ von Scholten… - Circulation …, 2021 - Am Heart Assoc
Background: The mechanism behind the cardiovascular protection observed with human
GLP-1 RA (glucagon-like peptide-1 receptor agonists) in type 2 diabetes is unknown. We …
GLP-1 RA (glucagon-like peptide-1 receptor agonists) in type 2 diabetes is unknown. We …
Ceramides and phospholipids are downregulated with liraglutide treatment: results from the LiraFlame randomized controlled trial
Introduction Treatment with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can
reduce risk of cardiovascular disease (CVD) in persons living with type 2 diabetes, however …
reduce risk of cardiovascular disease (CVD) in persons living with type 2 diabetes, however …
Cardiac autonomic function is associated with myocardial flow reserve in type 1 diabetes
EH Zobel, P Hasbak, SA Winther, CS Hansen… - Diabetes, 2019 - Am Diabetes Assoc
The link between cardiac autonomic neuropathy and risk of cardiovascular disease is
highlighted as an area in which research is needed. This study was undertaken to evaluate …
highlighted as an area in which research is needed. This study was undertaken to evaluate …